OCUL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.30%

Insider Buying (Last 12 Months): $69,600.00

Insider Selling (Last 12 Months): $535,597.46

Ocular Therapeutix Insider Trading History Chart

Ocular Therapeutix Share Price & Price History

^$11.25

▲ +0.16 (1.44%)

As of 07/16/2025 05:00 PM ET

Days: 30 | 90 | 365

Ocular Therapeutix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/23/2025	Jeffrey S. Heier	Insider	Sell	3,024	$7.18	$21,712.32	262,974
5/23/2025	Peter Kaiser	Insider	Sell	2,974	$7.17	$21,323.58	207,104
5/23/2025	Pravin Dugel	Insider	Sell	21,219	$7.18	$152,352.42	3,499,099
5/23/2025	Sanjay Nayak	Insider	Sell	1,862	$7.17	$13,350.54	281,623
5/8/2025	Richard L. Lindstrom	Director	Buy	10,000	$6.96	$69,600.00	172,704
2/24/2025	Pravin Dugel	Insider	Sell	21,475	$6.87	$147,533.25	3,520,318
2/4/2025	Donald Notman	Insider	Sell	11,119	$7.81	$86,839.39	193,444
1/31/2025	Donald Notman	Insider	Sell	6,301	$7.84	$49,399.84	204,563
11/25/2024	Jeffrey S. Heier	Insider	Sell	2,948	$9.01	$26,561.48	269,059
8/23/2024	Sanjay Nayak	Insider	Sell	1,832	$9.02	$16,524.64	176,194
5/23/2024	Sanjay Nayak	Insider	Sell	2,274	$5.84	$13,280.16	178,026
2/26/2024	Summer Road Llc	Major Shareholder	Buy	930,851	$7.52	$6,999,999.52	8,591,401
1/31/2024	Antony C. Mattessich	CEO	Sell	18,338	$4.95	$90,773.10	427,943
1/31/2024	Donald Notman	CFO	Sell	6,433	$4.95	$31,843.35	139,932
1/31/2024	Philip C Strassburger	General Counsel	Sell	6,831	$4.95	$33,813.45	109,218
1/31/2024	Rabia Gurses Ozden	Insider	Sell	7,764	$4.95	$38,431.80	92,767
8/30/2023	Antony C. Mattessich	CEO	Buy	6,500	$3.81	$24,765.00	6,500
7/7/2023	Rabia Gurses Ozden	Insider	Sell	832	$4.93	$4,101.76	100,531
2/6/2023	Antony C. Mattessich	CEO	Sell	19,669	$4.24	$83,396.56	446,281
2/6/2023	Christopher G White	Insider	Sell	5,829	$4.24	$24,714.96	94,766
2/6/2023	Donald Notman	CFO	Sell	6,476	$4.24	$27,458.24	139,387
2/6/2023	Philip C Strassburger	General Counsel	Sell	6,181	$4.24	$26,207.44	109,071
11/7/2022	Summer Road Llc	Major Shareholder	Buy	7,328	$3.50	$25,648.00	6,122,089
10/10/2022	Summer Road Llc	Major Shareholder	Buy	10,000	$4.00	$40,000.00	6,104,761
9/29/2022	Summer Road Llc	Major Shareholder	Buy	18,800	$4.04	$75,952.00	6,094,761
9/27/2022	Summer Road Llc	Major Shareholder	Buy	130,000	$4.68	$608,400.00	6,074,761

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

59.21% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ocular Therapeutix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/11/2025	Assenagon Asset Management S.A.	193,700	$1.80M	0.0%	-43.3%	0.122%
6/27/2025	Goldman Sachs Group Inc.	582,009	$4.27M	0.0%	-13.5%	0.365%
6/18/2025	Voya Investment Management LLC	336,516	$2.47M	0.0%	-9.4%	0.211%
5/29/2025	Rhumbline Advisers	223,115	$1.64M	0.0%	+4.5%	0.140%
5/16/2025	Woodline Partners LP	750,950	$5.50M	0.0%	-25.1%	0.471%
5/16/2025	Caxton Associates LLP	33,821	$0.25M	0.0%	N/A	0.021%
5/16/2025	Goldman Sachs Group Inc.	582,009	$4.27M	0.0%	-13.5%	0.365%
5/16/2025	Polar Asset Management Partners Inc.	56,670	$0.42M	0.0%	-85.6%	0.036%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	93,619	$0.69M	0.0%	+5.8%	0.059%
5/16/2025	AQR Capital Management LLC	15,650	$0.12M	0.0%	-40.4%	0.010%
5/16/2025	Adage Capital Partners GP L.L.C.	5,200,000	$38.12M	0.1%	+44.4%	3.264%
5/15/2025	Cubist Systematic Strategies LLC	137,871	$1.01M	0.0%	N/A	0.087%
5/15/2025	Paradigm Biocapital Advisors LP	1,314,018	$9.63M	0.5%	N/A	0.825%
5/15/2025	Second Line Capital LLC	346,098	$2.54M	0.7%	+1.8%	0.217%
5/15/2025	Panagora Asset Management Inc.	222,004	$1.63M	0.0%	-49.3%	0.139%
5/14/2025	Rafferty Asset Management LLC	11,070	$81K	0.0%	-27.3%	0.007%
5/14/2025	Pale Fire Capital SE	439,387	$3.22M	0.4%	-1.2%	0.276%
5/14/2025	EntryPoint Capital LLC	42,031	$0.31M	0.1%	N/A	0.026%
5/14/2025	Hsbc Holdings PLC	19,573	$0.14M	0.0%	+8.1%	0.012%
5/14/2025	Wellington Management Group LLP	452,964	$3.32M	0.0%	-3.1%	0.284%
5/13/2025	Northern Trust Corp	1,290,917	$9.46M	0.0%	-1.8%	0.810%
5/13/2025	Aptus Capital Advisors LLC	346,098	$2.54M	0.0%	+1.9%	0.217%
5/13/2025	Brooklyn Investment Group	5,238	$38K	0.0%	+151.5%	0.003%
5/13/2025	Algert Global LLC	29,020	$0.21M	0.0%	N/A	0.018%
5/13/2025	Summer Road LLC	13,878,018	$101.73M	98.2%	+0.1%	8.712%
5/12/2025	Nuveen LLC	414,104	$3.04M	0.0%	N/A	0.260%
5/12/2025	Aigen Investment Management LP	16,164	$0.12M	0.0%	-13.0%	0.010%
5/12/2025	Invesco Ltd.	804,829	$5.90M	0.0%	-9.6%	0.505%
5/9/2025	Deutsche Bank AG	258,225	$1.89M	0.0%	-43.4%	0.162%
5/9/2025	Charles Schwab Investment Management Inc.	1,112,793	$8.16M	0.0%	-1.7%	0.699%
5/9/2025	Vanguard Group Inc.	8,364,515	$61.31M	0.0%	-1.4%	5.251%
5/9/2025	Banco Santander S.A.	184,048	$1.35M	0.0%	+21.8%	0.116%
5/8/2025	XTX Topco Ltd	22,605	$0.17M	0.0%	+95.0%	0.014%
5/7/2025	Essex Investment Management Co. LLC	384,325	$2.82M	0.6%	-0.8%	0.241%
5/7/2025	Nottingham Advisors Inc.	33,083	$0.24M	0.0%	-66.2%	0.021%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	31,739	$0.23M	0.0%	-8.6%	0.020%
5/6/2025	Cetera Investment Advisers	721,364	$5.29M	0.0%	-0.3%	0.453%
5/6/2025	Legato Capital Management LLC	113,090	$0.83M	0.1%	-1.5%	0.071%
5/5/2025	Allianz Asset Management GmbH	37,500	$0.28M	0.0%	-41.9%	0.024%
5/2/2025	Graypoint LLC	20,194	$0.15M	0.0%	N/A	0.013%
5/2/2025	Victory Capital Management Inc.	16,150	$0.12M	0.0%	-76.6%	0.010%
4/30/2025	China Universal Asset Management Co. Ltd.	31,535	$0.23M	0.0%	-5.4%	0.020%
4/28/2025	Teacher Retirement System of Texas	25,382	$0.19M	0.0%	-8.6%	0.016%
4/28/2025	RoundAngle Advisors LLC	195,875	$1.44M	1.3%	-1.3%	0.123%
4/28/2025	Vontobel Holding Ltd.	10,784	$79K	0.0%	N/A	0.007%
4/25/2025	Peregrine Capital Management LLC	847,468	$6.21M	0.2%	N/A	0.533%
4/22/2025	Deltec Asset Management LLC	2,716,373	$19.91M	4.2%	+3.8%	1.708%
4/15/2025	Assenagon Asset Management S.A.	341,800	$2.51M	0.0%	N/A	0.215%
4/14/2025	Courier Capital LLC	154,266	$1.13M	0.1%	+173.3%	0.097%
4/8/2025	Rhumbline Advisers	223,115	$1.64M	0.0%	+4.5%	0.140%
4/7/2025	GAMMA Investing LLC	8,232	$60K	0.0%	+6,760.0%	0.005%
3/24/2025	Wellington Management Group LLP	467,352	$3.99M	0.0%	+1.0%	0.294%
3/18/2025	California State Teachers Retirement System	91,998	$0.79M	0.0%	-7.3%	0.058%
2/25/2025	Polar Asset Management Partners Inc.	394,400	$3.37M	0.0%	-20.0%	0.251%
2/19/2025	GF Fund Management CO. LTD.	3,301	$28K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	218,588	$1.87M	0.0%	+48.0%	0.139%
2/17/2025	Voloridge Investment Management LLC	33,483	$0.29M	0.0%	-71.4%	0.021%
2/17/2025	Woodline Partners LP	1,002,435	$8.56M	0.1%	+0.2%	0.638%
2/17/2025	Two Sigma Advisers LP	36,700	$0.31M	0.0%	+252.9%	0.023%
2/17/2025	Two Sigma Investments LP	252,939	$2.16M	0.0%	+21.9%	0.161%
2/17/2025	Second Line Capital LLC	340,098	$2.90M	0.8%	+29.4%	0.216%
2/17/2025	Rafferty Asset Management LLC	15,222	$0.13M	0.0%	-17.4%	0.010%
2/17/2025	Point72 Asset Management L.P.	2,935,924	$25.07M	0.1%	+43.9%	1.867%
2/17/2025	Polar Asset Management Partners Inc.	394,400	$3.37M	0.0%	-20.0%	0.251%
2/17/2025	ProShare Advisors LLC	51,270	$0.44M	0.0%	+32.8%	0.033%
2/17/2025	Patient Square Capital LP	470,919	$4.02M	1.5%	+100.0%	0.300%
2/17/2025	Nuveen Asset Management LLC	414,104	$3.54M	0.0%	-17.6%	0.263%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	270,422	$2.31M	0.2%	+22.0%	0.172%
2/17/2025	Millennium Management LLC	447,237	$3.82M	0.0%	N/A	0.284%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	88,463	$0.76M	0.0%	+3.3%	0.056%
2/17/2025	Graham Capital Management L.P.	37,577	$0.32M	0.0%	N/A	0.024%
2/17/2025	D. E. Shaw & Co. Inc.	31,419	$0.27M	0.0%	N/A	0.020%
2/17/2025	Deutsche Bank AG	456,120	$3.90M	0.0%	-45.3%	0.290%
2/17/2025	Deep Track Capital LP	12,836,282	$109.62M	4.1%	+0.9%	8.165%
2/17/2025	Cetera Investment Advisers	723,840	$6.18M	0.0%	+0.6%	0.460%
2/17/2025	Brevan Howard Capital Management LP	24,078	$0.21M	0.0%	N/A	0.015%
2/17/2025	Balyasny Asset Management L.P.	97,553	$0.83M	0.0%	N/A	0.062%
2/17/2025	Bank of America Corp DE	437,071	$3.73M	0.0%	-43.9%	0.278%
2/17/2025	BNP Paribas Financial Markets	75,400	$0.64M	0.0%	+110.6%	0.048%
2/17/2025	Ameriprise Financial Inc.	89,772	$0.77M	0.0%	+82.9%	0.057%
2/17/2025	Aptus Capital Advisors LLC	339,750	$2.90M	0.0%	+29.3%	0.216%
2/17/2025	Acuta Capital Partners LLC	1,111,071	$9.49M	9.5%	-6.6%	0.707%
2/14/2025	Freestone Grove Partners LP	13,931	$0.12M	0.0%	N/A	0.009%
2/14/2025	Nantahala Capital Management LLC	437,728	$3.74M	0.2%	-37.5%	0.278%
2/14/2025	Northern Trust Corp	1,314,871	$11.23M	0.0%	+5.5%	0.836%
2/14/2025	The Manufacturers Life Insurance Company	127,803	$1.09M	0.0%	-1.8%	0.081%
2/14/2025	Voya Investment Management LLC	371,235	$3.17M	0.0%	+35.7%	0.236%
2/14/2025	Adage Capital Partners GP L.L.C.	3,600,000	$30.74M	0.1%	-4.0%	2.290%
2/14/2025	Price T Rowe Associates Inc. MD	638,964	$5.46M	0.0%	-34.6%	0.406%
2/14/2025	Hsbc Holdings PLC	18,101	$0.15M	0.0%	+47.8%	0.012%
2/14/2025	Tower Research Capital LLC TRC	8,859	$76K	0.0%	+2,045.0%	0.006%
2/14/2025	MetLife Investment Management LLC	92,734	$0.79M	0.0%	+2.7%	0.059%
2/14/2025	First Trust Advisors LP	212,944	$1.82M	0.0%	N/A	0.135%
2/13/2025	CANADA LIFE ASSURANCE Co	30,227	$0.26M	0.0%	+152.4%	0.019%
2/13/2025	Walleye Capital LLC	10,548	$90K	0.0%	N/A	0.007%
2/13/2025	XTX Topco Ltd	11,593	$99K	0.0%	N/A	0.007%
2/13/2025	Barclays PLC	331,242	$2.83M	0.0%	-35.2%	0.211%
2/13/2025	Raymond James Financial Inc.	201,623	$1.72M	0.0%	N/A	0.128%
2/13/2025	Legal & General Group Plc	104,783	$0.90M	0.0%	-8.1%	0.067%
2/13/2025	Invesco Ltd.	890,046	$7.60M	0.0%	+17.8%	0.566%

Data available starting January 2016

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is developing AXPAXLI, an axitinib intravitreal implant that is in phase 3 trials for the treatment of wet age-related macular degeneration and other retinal diseases; PAXTRAVA, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company offers modulator for intermediate and late dry age-related macular degeneration; and gene delivery for inherited retinal degenerations and protein biofactory indications. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $11.25

$10.96

$11.39

50 Day Range

MA: $8.64

$6.93

$11.27

52 Week Range

Now: $11.25

$5.79

$11.78

Volume

2,123,286 shs

Average Volume

1,433,703 shs

Market Capitalization

$1.79 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43

Who are the company insiders with the largest holdings of Ocular Therapeutix?: Ocular Therapeutix's top insider investors include:
Summer Road Llc (Major Shareholder)
Pravin Dugel (Insider)
Antony C Mattessich (CEO)
Sanjay Nayak (Insider)
Jeffrey S Heier (Insider)
Peter Kaiser (Insider)
Donald Notman (Insider)
Richard L Md Lindstrom (Director)
Donald Notman (CFO)
Philip C Strassburger (General Counsel)
Rabia Gurses Ozden (Insider)
Learn More about top insider investors at Ocular Therapeutix.
Who are the major institutional investors of Ocular Therapeutix?: Ocular Therapeutix's top institutional investors include:
Assenagon Asset Management S.A. — 0.12%
Learn More about top institutional investors of Ocular Therapeutix stock.
Which major investors are selling Ocular Therapeutix stock?: In the previous quarter, OCUL stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Within the last year, company insiders that have sold Ocular Therapeutix company stock include:
Summer Road Llc (Major Shareholder)
Pravin Dugel (Insider)
Antony C Mattessich (CEO)
Sanjay Nayak (Insider)
Jeffrey S Heier (Insider)
Learn More investors selling Ocular Therapeutix stock.